Noble Wealth Management PBC »

Fs Global Cr Opportunitie Fda shares owned by Noble Wealth Management PBC

Quarter-by-quarter ownership of Fs Global Cr Opportunitie Fda (FSCO) shares owned by Noble Wealth Management PBC from 13F filings

Historical chart of Noble Wealth Management PBC investment in Fs Global Cr Opportunitie Fda

Tip: Access up to 7 years of quarterly data

All positions including Fs Global Cr Opportunitie Fda held by Noble Wealth Management PBC consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fs Global Cr Opportunitie Fda by Noble Wealth Management PBC

Quarter filed Position value Share count Share price at filing
2025-03-31 $1.3M 189k 7.05
2024-12-31 $3.3M 477k 6.82

More positions owned by Noble Wealth Management PBC

Apple Stock (AAPL)
Fidelity Investment Grade Bond Etf Etf (FIGB)
Ft Vest Laddered Buffer Etf Etf (BUFR)
Ishares Core S&p Small Cap Etf Etf (IJR)
Innovator U.s. Equity Power Buffer Etf - December Etf (PDEC)
Invesco S&p Smallcap Momentum Etf Etf (XSMO)
Fidelity Enhanced Mid Cap Etf Etf (FMDE)
Spdr Gold Shares Etf (GLD)
Goldman Sachs Equal Weight U.s. Large Cap Equity Etf Etf (GSEW)
Flaherty & Crumrine Total Retu Cef (FLC)
Angel Oak Finl Strategies Incm Com Ben Int Cef (FINS)
Ft Vest U.s. Equity Moderate Buffer Etf - June Etf (GJUN)
Pimco Income Strategy Fd Ii Cef (PFN)
Invesco Qqq Trust Series I Etf (QQQ)
Ft Vest U.s. Small Cap Moderate Buffer Etf - November Etf (SNOV)

View all positions for Noble Wealth Management PBC

Top funds holding Fs Global Cr Opportunitie Fda

Commonwealth Equity Services
Cambridge Investment Research Advisors
Cetera Investment Advisers
Sit Investment Associates
LPL Financial
Vista Finance
H D Vest Advisory Services
Blackstone Group
Rockefeller Capital Management
Advisor Group Holdings
Morgan Stanley
Summit Financial
Envestnet Asset Management
Thomas J. Herzfeld Advisors
Ellis Investment Partners

View all funds holding Fs Global Cr Opportunitie Fda